No FDA-regulated manufacturers are inspected more rigorously than API firms.
These companies’ specialized operations, and their crucial role in the drug-making process, make them frequent FDA inspection targets.
There’s a lot that can be learned from the 483s resulting from such inspections — for both the API manufacturers and for the drug and biologics makers that do business with them.
Discover what the FDA inspectors are after … and what they find … in this Form 483 compilation.
From FDAnews
Form 483 Watch: Focus on API Manufacturers
Imagine having access to recent FDA inspection reports on API manufacturers — especially if they’re your competitors — whenever you need them.
Well, now you can. In fact, you can have immediate access to 50 recent 483s, compiled in one, easy-to-access volume, with this collection from FDAnews.
Of course, you know that a Form 483 is the FDA’s most detailed public record of inspection findings.
But, a 483 is also invaluable “inside intelligence” when you want to know what FDA inspectors have found in other companies and what they’ll look for on inspection day in your own.
Here’s just a glimpse of what you’ll discover:
Collecting and compiling these 483s is not a task to undertake on your own. You’d spend days at it (even weeks!) at a cost of thousands of dollars in fees before you’d finished. But now you can get them much more easily — and less expensively.
Simply order Form 483 Watch: Focus on API Manufacturers from FDAnews. For API or finished pharmaceutical manufacturers preparing for inspection, Form 483 Watch is a must-have reference you can’t afford to be without.
Whether you work in regulatory affairs, quality control or on the factory floor, you’ll find real-life details (and read between the lines) about how the FDA does its job, what catches the inspector’s eye, and what you should do now to avoid problems experienced by other API manufacturers.
Buy Now!
Form 483 Watch: Focus on API Manufacturers is available in PDF format for $377.
Satisfaction Guaranteed
There's no risk when you purchase from FDAnews with our money-back guarantee. Not satisfied with your publication? For the PDF, you must notify FDAnews within
24 hours of receipt of purchase to receive a refund.
|
Interested in purchasing more than one print copy? Significant volume discounts are available for ordering three or more copies of the same book. You must order them at the same time and provide a single payment to take advantage of the discount. Order below by clicking submit and then change your quantity in the shopping cart. The discount will be calculated automatically.
Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally with any questions.
Interested in Electronic Multi-user Access? Phone: +1 (703) 538-7600 or toll free (888) 838-5578 Email: customerservice@fdanews.com |